{
    "@graph": [
        {
            "@id": "gnd:128651539",
            "sameAs": "Snyder, Christopher M."
        },
        {
            "@id": "gnd:130514845",
            "sameAs": "Glennerster, Rachel"
        },
        {
            "@id": "gnd:1319350461",
            "sameAs": "Kelly, Thomas"
        },
        {
            "@id": "gnd:131935078X",
            "sameAs": "McMahon, Claire T."
        },
        {
            "@id": "gnd:39157-8",
            "sameAs": "National Bureau of Economic Research"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A1880205653",
            "@type": "bibo:Book",
            "P1053": "1 Online-Ressource",
            "description": [
                "Campusweiter Zugriff (Universit\u00e4t Hannover) - Vervielf\u00e4ltigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.",
                "illustrations (black and white)"
            ],
            "identifier": [
                "(ppn)1880205653",
                "(firstid)KEP:100458971"
            ],
            "publisher": "National Bureau of Economic Research",
            "subject": [
                "Impfung",
                "Government Policy; Regulation; Public Health",
                "Chemicals; Rubber; Drugs; Biotechnology; Plastics",
                "Coronavirus",
                "USA",
                "Arzneimittel",
                "(classificationName=linseach:automatic)mat",
                "Soziale Werte",
                "Gesundheitsversorgung",
                "Government Expenditures and Health"
            ],
            "title": "Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development",
            "abstract": "A booster of the COVID-19 vaccine targeting the prevailing Omicron variant did not become available in the United States until a year after the variant was first detected. This pattern of developing, testing, and distributing a variant-specific booster may become the default response to further waves of COVID-19 caused by new variants. An innovation with realistic scientific potential--a universal COVID-19 vaccine, effective against existing and future variants--could provide much more value by preempting new variants. Averaged across Monte Carlo simulations, we estimate the incremental value to the U.S. population of a universal COVID-19 vaccine to be $1.5-$2.6 trillion greater than variant-specific boosters (depending on how the arrival rate of variants is modeled). This social value eclipses the cost of an advance market commitment to incentivize the universal vaccine by several orders of magnitude",
            "contributor": "Technische Informationsbibliothek (TIB)",
            "creator": [
                "gnd:1319350461",
                "gnd:130514845",
                "gnd:39157-8",
                "gnd:128651539",
                "gnd:131935078X"
            ],
            "isPartOf": "(collectioncode)ZDB-194-NBW",
            "issued": "2024",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "commercial licence",
            "medium": "rda:termList/RDACarrierType/1018",
            "volume": "no. w32059",
            "P30128": "NBER working paper series",
            "P60163": "Cambridge, Mass"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "abstract": "http://purl.org/dc/terms/abstract",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "license": "http://purl.org/dc/terms/license",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "creator": {
            "@id": "http://purl.org/dc/terms/creator",
            "@type": "@id"
        },
        "issued": "http://purl.org/dc/terms/issued",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "description": "http://purl.org/dc/elements/1.1/description",
        "P30128": "http://www.rdaregistry.info/Elements/m/#P30128",
        "volume": "http://purl.org/ontology/bibo/volume",
        "title": "http://purl.org/dc/elements/1.1/title",
        "contributor": "http://purl.org/dc/terms/contributor",
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}